Atlas Trials

Effects of Pre-emptive Scalp Infiltration With Ketorolac and Ropivacaine for Post-craniotomy Pain

Clinical trial NCT04141319 · UNKNOWN

Trial details

NCT number
NCT04141319
Sponsor
Beijing Tiantan Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
PainSupratentorial Brain Tumor
Start date
2021-12-01
Primary completion
2022-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.